Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study

Overview of attention for article published in Advances in Therapy, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Readers on

mendeley: 74 Mendeley

Summary Policy documents X

So far, Altmetric has seen 1 policy document that references this research output.

Type 2 diabetes in adults: management : March 2018: evidence reviews for SGLT-2 inhibitors and GLP-1 mimetics

Cited by National Institute for Health and Care Excellence on 05 Mar 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.